David Smith
Net worth: 2 M $ as of 30/09/2026
Net worth: 2 M $ as of 30/09/2026
Dr. David A. Smith is a Non-Executive Chairman at TheraCryf Plc, an Independent Non-Executive Director at Thalia Therapeutics Plc and a Non-Executive Chairman at SPARTA Biodiscovery Ltd. He is on the Board of Directors at Thalia Therapeutics Plc and Nextmune Laboratories Ltd. Dr. Smith was previously employed as a Chief Executive Officer & Executive Director by Avacta Group Plc, a Chief Executive Officer & Director by Avacta Life Sciences Ltd., and a Director-Institute of Molecular Biophysics by University of Leeds.
He also served on the board at TheraGenetics Ltd. He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVACTA GROUP PLC 0.33% | 04/06/2025 | 15,65,100 ( 0.33% ) | 1 M $ | 30/09/2026 |
THERACRYF PLC 1.33% | 09/09/2026 | 3,62,12,888 ( 1.33% ) | 86 549 $ | 30/09/2026 |
| Companies | Position | Start |
|---|---|---|
| THALIA THERAPEUTICS PLC | Director/Board Member | 08/01/2025 |
| THERACRYF PLC | Chairman | 19/02/2025 |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Chairman | - |
Avacta Animal Health Ltd.
Avacta Animal Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides veterinary allergy diagnostic solutions through laboratories | Director/Board Member | 06/02/2009 |
| Companies | Position | End |
|---|---|---|
| AVACTA GROUP PLC | Founder | 01/05/2024 |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | - |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Director/Board Member | - |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Evgen Pharma Plc
Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Manchester
The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Health Technology |
Avacta Animal Health Ltd.
Avacta Animal Health Ltd. Miscellaneous Commercial ServicesCommercial Services Provides veterinary allergy diagnostic solutions through laboratories | Commercial Services |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
N4 Pharma Plc
N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Health Technology |
Select your edition
All financial news and data tailored to specific country editions